HitGen
HitGen is a platform company based on its leading DNA-encoded library (DELs) technology for innovative drug discovery research. Learn more
Launch date
Employees
Market cap
CAD643m
Enterprise valuation
CAD510m (Public information from Sep 2024)
Share price
CNY8.49 688222.SS
Chengdu Sichuan (HQ)
Authorizing premium user...